Rosa is a 55-year-old moderately obese Hispanic woman (body mass index is 29). She was referred to you when her gynecologist noted glucose on a routine urinalysis. She subsequently has an FPG of 190 and 200 mg/dL on two separate occasions. She is thirstier than usual and has more frequent urination. She also complains of decreased energy over the last several months and numbness and tingling in her left lower extremity.

Family history:

• Sister, mother, and maternal grandmother have diabetes.

Social history:

• Nonsmoker, drinks alcohol socially (one drink about three times a month), and does not exercise.

Review of systems:

• 20 lb weight gain over the past two years, has some blurred vision, has had two urinary tract infections in the past year, and has frequent vaginal yeast infections.
• Gestational diabetes in last two pregnancies.

Physical exam:

• Unremarkable except blood pressure of 150/90
• Height: 5 feet 2 inches
• Weight: 200 lb
• Laboratory results: FPG 200 mg/dL, HbA1C 10%, LDL 160 mg/dL, HDL 35 mg/dL, total cholesterol 248 mg/dl and triglycerides 266 mg/dL

Allergy:

• NKDA

Diagnosis: Type 2 Diabetes Mellitus

1. List specific goals for the treatment for Rosa.

2. What dietary and lifestyle changes would you recommend for Rosa?

3. What drug therapy would you prescribe? Why?

4. What is the goal for the FPG? Postprandial glucose? HbA1C?

5. Discuss specific education for Rosa based on the prescribed therapy.

6. List one or two adverse reactions for the therapy selected that would cause you to change the therapy.

7. If the HbA1C after three months on the prescribed therapy is 8.8%, what would be the next line of therapy? Provide rationale for your answer.

8. What over-the-counter or herbal medicines might be appropriate for Rosa?

9. Describe one or two drug-drug or drug-food interactions for the selected agent.

ref:

Wexler, D. J. (2022). Initial management of hyperglycemia in adults with type 2 diabetes mellitus. UpToDate. https://www.uptodate.com/contents/initial-management-of-hyperglycemia-in-adults-with-type-2-diabetes-mellitus

Wexler, D. J., Nathan, D. M., & Rubinow, K. (n.d.). Patient education: Type 2 diabetes: Treatment (Beyond the Basics). UpToDate. https://www.uptodate.com/contents/type-2-diabetes-treatment-beyond-the-basics/print

ANSWER

Comprehensive Management of Type 2 Diabetes Mellitus in Rosa: A Patient Case Study

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder that requires a multifaceted approach to management. In the case of Rosa, a 55-year-old Hispanic woman diagnosed with T2DM, a tailored treatment plan is essential to achieve optimal glycemic control, mitigate complications, and improve overall quality of life. This essay outlines specific goals, dietary and lifestyle recommendations, drug therapy, education, potential adverse reactions, and further steps for Rosa’s diabetes management.

Specific Goals for Treatment

Achieve glycemic control by targeting a fasting plasma glucose (FPG) level below 130 mg/dL.
Reduce HbA1C levels to less than 7% to minimize the risk of diabetes-related complications.
Manage blood pressure to a target of less than 130/80 mmHg.
Improve lipid profile by increasing HDL and reducing LDL and triglycerides.
Alleviate symptoms such as increased thirst, frequent urination, numbness, and tingling.

Dietary and Lifestyle Changes

Implement a balanced, low-glycemic index diet rich in whole grains, lean proteins, fruits, vegetables, and healthy fats.
Encourage regular physical activity, aiming for at least 150 minutes of moderate-intensity aerobic exercise per week.
Emphasize portion control, mindful eating, and avoidance of sugary beverages and processed foods.
Monitor carbohydrate intake and distribute meals evenly throughout the day to maintain consistent blood sugar levels.

Drug Therapy

Considering Rosa’s elevated FPG and HbA1C levels, initiating metformin therapy is recommended as the first-line oral antidiabetic agent. Metformin improves insulin sensitivity and inhibits hepatic glucose production. It is suitable for Rosa due to its low risk of hypoglycemia, moderate weight loss effect, and potential cardiovascular benefits.

Glycemic Goals

FPG: Less than 130 mg/dL.
Postprandial glucose: Less than 180 mg/dL.
HbA1C: Less than 7%.

Patient Education

Rosa should receive comprehensive education on:
Proper medication administration, potential side effects, and regular monitoring.
Self-monitoring of blood glucose (SMBG) to track glycemic levels.
Importance of regular physical activity and its impact on glycemic control.
Meal planning, carbohydrate counting, and portion control.
Recognition of symptoms of hyperglycemia and hypoglycemia and appropriate actions.

Adverse Reactions and Therapy Modification

Metformin can cause gastrointestinal side effects such as nausea and diarrhea. If these symptoms persist or worsen, Rosa’s therapy may need to be adjusted. Regular monitoring of renal function is crucial due to metformin’s potential impact on kidney function.

Next Line of Therapy

If HbA1C remains elevated at 8.8% after three months, consideration should be given to adding a second oral agent, such as a dipeptidyl peptidase-4 (DPP-4) inhibitor or a glucagon-like peptide-1 (GLP-1) receptor agonist, to enhance glycemic control.

Over-the-Counter or Herbal Medicines

Rosa should consult her healthcare provider before using any over-the-counter or herbal medicines, as potential interactions with prescribed medications may occur.

Drug-Drug or Drug-Food Interactions

Metformin can interact with certain medications, including cimetidine and some sulfonylureas, potentially leading to increased metformin levels and the risk of lactic acidosis. Grapefruit juice may affect drug metabolism and should be avoided.

In conclusion, Rosa’s T2DM management requires a comprehensive approach involving lifestyle modifications, medication therapy, patient education, and ongoing monitoring. Tailoring her treatment plan to address specific goals and individual needs will enhance her glycemic control, reduce complications, and ultimately improve her overall health and well-being.